These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38886573)

  • 1. The importance of 3D fibre architecture in cancer and implications for biomaterial model design.
    Ashworth JC; Cox TR
    Nat Rev Cancer; 2024 Jul; 24(7):461-479. PubMed ID: 38886573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biomimetic extracellular matrix: a therapeutic tool for breast cancer research.
    Tamayo-Angorrilla M; López de Andrés J; Jiménez G; Marchal JA
    Transl Res; 2022 Sep; 247():117-136. PubMed ID: 34844003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D bioprinting complex models of cancer.
    Sharma R; Restan Perez M; da Silva VA; Thomsen J; Bhardwaj L; Andrade TAM; Alhussan A; Willerth SM
    Biomater Sci; 2023 May; 11(10):3414-3430. PubMed ID: 37000528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in biofabrication techniques for collagen-based 3D in vitro culture models for breast cancer research.
    Redmond J; McCarthy H; Buchanan P; Levingstone TJ; Dunne NJ
    Mater Sci Eng C Mater Biol Appl; 2021 Mar; 122():111944. PubMed ID: 33641930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments.
    Taubenberger AV; Bray LJ; Haller B; Shaposhnykov A; Binner M; Freudenberg U; Guck J; Werner C
    Acta Biomater; 2016 May; 36():73-85. PubMed ID: 26971667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific parameters for the design of ECM-mimetic biomaterials.
    Tonti OR; Larson H; Lipp SN; Luetkemeyer CM; Makam M; Vargas D; Wilcox SM; Calve S
    Acta Biomater; 2021 Sep; 132():83-102. PubMed ID: 33878474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recreating the extracellular matrix: novel 3D cell culture platforms in cancer research.
    Kyriakopoulou K; Koutsakis C; Piperigkou Z; Karamanos NK
    FEBS J; 2023 Nov; 290(22):5238-5247. PubMed ID: 36929947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution fibre spinning technique for the fabrication of tuneable decellularised matrix-laden fibres and fibrous micromembranes.
    Li Z; Tuffin J; Lei IM; Ruggeri FS; Lewis NS; Gill EL; Savin T; Huleihel L; Badylak SF; Knowles T; Satchell SC; Welsh GI; Saleem MA; Huang YYS
    Acta Biomater; 2018 Sep; 78():111-122. PubMed ID: 30099199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodelling of the fibre-aggregate structure of collagen gels by cancer-associated fibroblasts: A time-resolved grey-tone image analysis based on stochastic modelling.
    Gommes CJ; Louis T; Bourgot I; Noël A; Blacher S; Maquoi E
    Front Immunol; 2022; 13():988502. PubMed ID: 36818478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Scale Degradation of Peritumoural Extracellular Matrix Fibre Network and Its Role Within Tissue-Scale Cancer Invasion.
    Shuttleworth R; Trucu D
    Bull Math Biol; 2020 May; 82(6):65. PubMed ID: 32458057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining a turnover index for the correlation of biomaterial degradation and cell based extracellular matrix synthesis using fluorescent tagging techniques.
    Bardsley K; Wimpenny I; Wechsler R; Shachaf Y; Yang Y; El Haj AJ
    Acta Biomater; 2016 Nov; 45():133-142. PubMed ID: 27592815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decellularized Extracellular Matrix for Bioengineering Physiomimetic 3D in Vitro Tumor Models.
    Ferreira LP; Gaspar VM; Mano JF
    Trends Biotechnol; 2020 Dec; 38(12):1397-1414. PubMed ID: 32416940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in Extracellular Matrix-Based Biomaterials and Biofabrication of 3D Organotypic Skin Models.
    Phang SJ; Basak S; Teh HX; Packirisamy G; Fauzi MB; Kuppusamy UR; Neo YP; Looi ML
    ACS Biomater Sci Eng; 2022 Aug; 8(8):3220-3241. PubMed ID: 35861577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.
    Ingavle G; Das M
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4673-4696. PubMed ID: 36194142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatio-temporal remodelling of the composition and architecture of the human ovarian cortical extracellular matrix during in vitro culture.
    Grosbois J; Bailie EC; Kelsey TW; Anderson RA; Telfer EE
    Hum Reprod; 2023 Mar; 38(3):444-458. PubMed ID: 36721914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomaterials approaches to modeling macrophage-extracellular matrix interactions in the tumor microenvironment.
    Springer NL; Fischbach C
    Curr Opin Biotechnol; 2016 Aug; 40():16-23. PubMed ID: 26921768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance.
    Schwartz AD; Barney LE; Jansen LE; Nguyen TV; Hall CL; Meyer AS; Peyton SR
    Integr Biol (Camb); 2017 Dec; 9(12):912-924. PubMed ID: 29159332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D biomaterial models of human brain disease.
    Kajtez J; Nilsson F; Fiorenzano A; Parmar M; Emnéus J
    Neurochem Int; 2021 Jul; 147():105043. PubMed ID: 33887378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the tumor extracellular matrix: Tissue engineering tools repurposed towards new frontiers in cancer biology.
    Gill BJ; West JL
    J Biomech; 2014 Jun; 47(9):1969-78. PubMed ID: 24300038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstructing the tumor architecture into organoids.
    Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
    Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.